Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

September 29, 2023

Study Completion Date

October 31, 2023

Conditions

Non-Alcoholic Fatty Liver DiseaseFecal Microbiota Transplantation

Interventions

OTHER

Faecal microbiota transplant

Capsulised faecal microbiota transplant prepared from rationally selected donor, based upon donor metabolomic charateristics

Trial Locations (1)

Division of Digestive Diseases/ Liver Unit, St Mary's Hospital Campus, Imperial College London, London

All Listed Sponsors

collaborator

King's College London

OTHER

lead

Imperial College London

OTHER

NCT06024681 - Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis | Biotech Hunter | Biotech Hunter